Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aram F Hezel

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Expert Opinion on Investigational Drugs|May 16, 2007
Emerging therapies for colorectal cancerAram F Hezel, David P Ryan
Oncotargets and Therapy|November 9, 2013
New and emerging treatment options for biliary tract cancerMarcus S Noel, Aram F Hezel
The Oncologist|May 2, 2008
Systemic therapy for biliary tract cancersAram F Hezel, Andrew X Zhu
Hepatology (Baltimore, Md.)|January 29, 2011
Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunitiesAndrew X Zhu, Aram F Hezel
Hematology/Oncology Clinics of North America|August 1, 2015
Genetics and Biology of Pancreatic Ductal AdenocarcinomaRichard F Dunne, Aram F Hezel
Autophagy|July 4, 2012
Autophagy in intra-hepatic cholangiocarcinomaJing Li Huang, Aram F Hezel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Genetics of biliary tract cancers and emerging targeted therapiesAram F Hezel, Vikram Deshpande, Andrew X Zhu
Case Reports in Oncology|February 28, 2014
Stereotactic body radiation therapy as a bridge to transplantation and for recurrent disease in the transplanted liver of a patient with hepatocellular carcinomaAli Mazloom, Aram F Hezel, Alan W Katz
Current Molecular Medicine|June 25, 2005
Telomere induced senescence: end game signalingAram F Hezel, Nabeel Bardeesy, Richard S Maser
The Oncologist|February 12, 2010
Current management of gallbladder carcinomaAndrew X Zhu, Theodore S Hong, Aram F Hezel, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|May 16, 2007
Emerging therapies for colorectal cancerAram F Hezel, David P Ryan
Oncotargets and Therapy|November 9, 2013
New and emerging treatment options for biliary tract cancerMarcus S Noel, Aram F Hezel
The Oncologist|May 2, 2008
Systemic therapy for biliary tract cancersAram F Hezel, Andrew X Zhu
Hepatology (Baltimore, Md.)|January 29, 2011
Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunitiesAndrew X Zhu, Aram F Hezel
Hematology/Oncology Clinics of North America|August 1, 2015
Genetics and Biology of Pancreatic Ductal AdenocarcinomaRichard F Dunne, Aram F Hezel
Autophagy|July 4, 2012
Autophagy in intra-hepatic cholangiocarcinomaJing Li Huang, Aram F Hezel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Genetics of biliary tract cancers and emerging targeted therapiesAram F Hezel, Vikram Deshpande, Andrew X Zhu
Case Reports in Oncology|February 28, 2014
Stereotactic body radiation therapy as a bridge to transplantation and for recurrent disease in the transplanted liver of a patient with hepatocellular carcinomaAli Mazloom, Aram F Hezel, Alan W Katz
Current Molecular Medicine|June 25, 2005
Telomere induced senescence: end game signalingAram F Hezel, Nabeel Bardeesy, Richard S Maser
The Oncologist|February 12, 2010
Current management of gallbladder carcinomaAndrew X Zhu, Theodore S Hong, Aram F Hezel, et al.
Pageof 7